期刊文献+

痛风患者大动脉粥样硬化的发生率及其规律分析 被引量:2

Incidence rate of aortic atherosclerosis in patients with gout and the regularity
暂未订购
导出
摘要 目的:分析痛风患者大动脉粥样硬化特征,寻找其规律性。方法:选择近期做完腹部CT检查的55例痛风患者按相同性别、年龄、身高、体质量和其他心血管危险因素与血尿酸正常1∶1配对(对照组),比较腹主动脉钙化率和钙化体积。结果:55例痛风患者中,腹主动脉钙化率为74.5%(41例),钙化体积为犤(0.76±0.19)cm3犦,明显高于对照组(χ2=12.274,P<0.001和t=3.953,P<0.01)。在按不同血尿酸水平分组后,重度升高组(≥150mg/L,11例)的腹主动脉钙化体积犤(0.99±0.31)cm3犦明显高于中度(90~140mg/L,21例)犤(0.85±0.26)cm3犦和轻度升高组(<90mg/L,23例)犤(0.67±0.22)cm3犦(t=2.145和3.164,P<0.01和0.05)。在按有无合并危险因素及合并多少分组后,合并多项危险因素患者(24例)的腹主动脉钙化体积和钙化率明显高于不合并组(t=3.375,P<0.01和χ2=7.309,P<0.01)。结论:痛风患者常有较严重的大动脉粥样硬化,大动脉粥样硬化发生频度和程度与痛风患者血尿酸升高水平和合并危险因素多少有一定关系。 AIM:To analyze the characteristics of aortic atherosclerosis in patients with gout, and to explore its regularity. METHODS:After examining abdominal CT,55 patients with gout were matched with normal subjects with normal uric acid(control group) at the ratio of 1 to 1 by same sex,age,height,body mass and other cardiovascular risk factors,to compare the calcification rate and volume of abdominal aorta. RESULTS:The calcification rate and volume of abdominal aorta were 74.5%(41 cases)and(0.76±0.19)cm3 for the patients with gout,obviously higher than those in the control group(χ2=12.274,P< 0.001 and t=3.953,P< 0.01). According to uric acid level,the calcification volume in severe elevated group(≥15.0 mg/L,11 cases)[(0.99±0.31) cm3] was obviously higher than those in the moderate(90-140 mg/L,21 cases)[(0.85±0.26) cm3] and mild elevated groups(< 90 mg/L,23 cases)[(0.67±0.22) cm3](t=2.145,3.164,P< 0.01 and 0.05).According to whether the subjects have risk factors or not, the calcification rate and volume of abdominal aorta in the multiple risk factors group(24 cases) were obviously higher than those in the non risk factor group(13 cases)(t=3.375,P< 0.01 and χ2=7.309,P< 0.01). COUCLUSION:Patients with gout are always complicated with severe aortic atherosclerosis,and the incidence rate and degree have a certain relation with the elevated level of uric acid and risk factor of the patients.
出处 《中国临床康复》 CSCD 2004年第18期3502-3503,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献13

  • 1Hoieggen A,Alderman MH.Kjeldsen SE et al. LIFE Study Group The impact of serum uric acid on cardiovascular outcomes inthe LIFE study.Kidney Int 2004;65(3):1041-9
  • 2Hsu SP.Pai MF.Peng YS,et al. Serum uric acidlevels show a 'J-shaped'association with all-cause mortality jn haemodialysis patients Nephrol Dial Transplant 2004;19(2):457-62
  • 3Ihara H.Hashizume N,Hasegawa T,et al. Antioxidant capacities of ascorbic acid,uric acid,alpha-tocopherol,and bilirubin can be measured in the presence of another antioxidant,serun albumin. J Clin Lab Anal 2004;18(1):45-9
  • 4Waring WS, Adwani SH, Breukels O, et al. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004; 90(2): 155 -9
  • 5Anetor JI, Ajose OA, lge O, et al. Antioxidant status of adult Nigerian asthmatics:implications for prognosis. Nutr Health 2003; 17 (3): 221 - 9
  • 6Deepa PR, Varalakshmi P. Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin Chim Acta 2004;339(1 -2): 105 - 15
  • 7Ben Salem F, Ben Salem K, Grati L, et al. Risk factors for eclampsia: a case-control study. Ann Fr Anesth Reanim 2003; 22 (10):865 -9
  • 8Koguchi T, Nakajima H, Koguchi H, et al. Suppressive effect of viscous dietary fiber on elevations of uric acid in serum and urine induced by dietary RNA in rats is associated with strength of viscosity. Int J Vitam Nutr Res 2003: 73(5): 369 -76
  • 9Carnethon MR, Fortmann SP, Palaniappan L, et al. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study 1987 -1998. Am J Epidemiol 2003; 158 ( 11 ): 1058 - 67
  • 10Salako BL, Odukogbe AT, Olayemi O, et al. Serum albumin, creatinine, uric acid and hypertensive disorders of pregnancy. East A fr Med J 2003; 80(8): 424 - 8

二级参考文献12

  • 1Bi LQ, Li P. Concept of gout and its pathogenesis. Zhongguo Shequ Yishi 2002:(7):12.
  • 2Clive DM. Renal transplant associated hyperuricemia and gout. J Am Soc Nephrol 2000:11 : 974 - 9.
  • 3Xiong MQ, Deng ZZ. Endocrine diseases and gout. Bering: People' s Health Publishing House 2001:273.
  • 4Li H, Zhang MX, Xiao J. Determination of blood uric acid and associated diseases in 879 middle and old-age patients. Shiyong Laonian Yixue 2001 ; 15 (4) : 15.
  • 5Wang ZG, Zhu ZM,Yuan KS, et al. Relationship between obesity index and level of blood uric acid. Zhongguo Linchuang Kangfu 2002; 6(30):1941.
  • 6Bickel C, Hans J,Rupprecht MD, et al. Serum uric acid an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002: 89:12 - 7.
  • 7Hu HX, Shi ZS, Hu YH, et al. Advances in gout. Zhongyiyao Xinxi Zazhi 1997;4(6):21 -2.
  • 8Li D, Cao LH, Zhang HY,et al. Analysis on 370 High urine sour blood disease. Zhonghua Fengshibingxue Zazhi 1999:3(4):244-6.
  • 9Gao ZM, Xu ZR. Clinical study on domestic Bensbromarone in decreasing blood uric acid. Jiaotong Yixue 2002; 16(15) :531.
  • 10Paacuat E. Gout update: from lab to the clinic and back. Curt Open Rheumatol 2000;12(3): 213-8.

共引文献15

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部